Inventor · name-matched record
ULLMAN ERICA
3 granted patents·1 pending application·0 citations·filing 2022–2025
41Inventor score
Technology areasC07K
Files withREGENERON PHARMA4
This identity is grouped by exact name match (no disambiguated inventor record was available for these filings) — it may combine same-named inventors.
Top patents by PatentIndex Score
4 records- 0177US12590168B2Antigen-binding molecules that bind CD38 and/or CD28, and uses thereofREGENERON PHARMA·Filed 2024·Granted Mar 31, 2026·0 cites·35 claims
- 0259US12528851B2IL2-based therapeutics and methods of use thereofREGENERON PHARMA·Filed 2022·Granted Jan 20, 2026·0 cites·44 claims
- 0359US12522638B2IL12 receptor agonists and methods of use thereofREGENERON PHARMA·Filed 2022·Granted Jan 13, 2026·0 cites·13 claims
- 0456US2026014252A1GPRC5D x CD28 Bispecific Antibodies and Methods of Use ThereofREGENERON PHARMA·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ULLMAN ERICA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: exact name match across USPTO filings. How scoring works →